◆ 会议时间:2022年3月3日至5日
◆ 会议地点:比利时 布鲁塞尔/Brussels, Belgium
◆ 会议简介:
2022年国际头颈部肿瘤创新方法大会(ICHNO)/欧洲头颈部肿瘤学大会(ECHNO)将于2022年3月3日至5日在比利时布鲁塞尔举行会议由欧洲放射治疗与肿瘤学学会(ESTRO)、欧洲头颈学会(EHNS)和欧洲肿瘤内科学会(ESMO)联合主办,每两年举办一次,ICHNO是宣推动多学科头颈部肿瘤学发展的国际盛会。ICHNO将成为一个独特的传播头颈部肿瘤学领域最相关和最前沿的科学与创新的平台。——领域国际医学会议网翻译整理,未经本站许可禁止复制摘录转载本站任何内容(lingyuint.com)。
International Congress on Innovative Approaches in Head and Neck Oncology (ICHNO) and the European Congress on Head and Neck Oncology (ECHNO)
Date: 3 - 5 March 2022
Vneue: Square – Brussels Convention Centre / Brussels, Belgium
重要日期:
Abstract submission deadline: 13 October 2021
Early registration deadline: 15 December 2021
Late registration deadline: 2 February 2022
Desk registration: as of 3 February 2022
点此提交摘要>>>Submit Abstract>>>
摘要提交指南>>>Abstract submission guidelines>>>
The joint International Congress on Innovative Approaches in Head and Neck Oncology (ICHNO) and the European Congress on Head and Neck Oncology (ECHNO) is taking place in Brussels, Belgium from 3 to 5 March 2022.
The European SocieTy for Radiotherapy and Oncology (ESTRO), the European Head and Neck Society (EHNS) and the European Society of Medical Oncology (ESMO) have the pleasure to invite you to participate in this congress.
This joint congress promises to provide a unique platform for the dissemination of the most relevant and cutting-edge science and innovation in the field of head and neck oncology. ICHNO and ECHNO, biannual congresses respectively, promote multidisciplinarity in head and neck oncology.
This joint meeting will specifically cover the main following topics:
- New insights in the epidemiology and prevention of H&N cancer
- Oncogenesis, HPV related cancers, immunology and vaccination
- Updated results of practice changing randomised trials
- Multidisciplinary management of H&N cancers
- Molecular targeted therapies and molecular imaging
- Novel radiation and surgical treatments
- Towards individualised management of H&N cancer
- Robotic and minimally invasive surgery
- Reconstructive and salvage surgery
- Elderly patients, co-morbidities and their impact on management
- New insight in systemic treatments of H&N cancers
- Thyroid, nasopharynx cancers and rare H&N cancers
- Quality of life, supportive care and management of treatment side effects
The format of the meeting will include prestigious invited ‘state of the art lectures’; lectures on the latest innovative approaches; proffered papers and poster presentations of new data in the field of head and neck oncology. The programme will be enriched by pro and contra debates and Interactive tumour board sessions where the audience will have the possibility to participate and share their input via an electronic voting system. There will be also a special focus on presentations of new data from practice changing randomised trials. Ample time will be given for discussions to allow in-depth interaction among the various disciplines and the participants.
To stimulate multidisciplinary interactions among the various specialists, all the lectures, debates, tumour boards and proferred papers will be given in the same congress room.
It is hoped that the mix of a rich and challenging scientific programme coupled with the quintessential atmosphere of Europe’s capital will convince you to attend the joint ICHNO-ECHNO 2022 congress.
Pierre Blanchard |
Wojciech Golusinski |
Sjoukje Oosting |
ESTRO |
EHNS |
ESMO |
◆ 参会对象:医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。 |